Showing all 10 results
Glibenclamide & Metformin Hydrochloride Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for flexible clinical titration.
Active Ingredient Standard Strengths (per Tablet) Primary Clinical Function Metformin HCl 400 mg / 500 mg The Foundation: Reduces glucose production. Glibenclamide (Glyburide) 2.5 mg / 5 mg The Stimulator: Enhances insulin secretion. Excipients Pharma Grade The Matrix: Ensures stability of the FDC. Glibenclamide, Metformin & Pioglitazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the three highly reactive APIs.
Active Ingredient Strength Primary Clinical Function Glibenclamide USP/Ph.Eur. 5 mg The Secretagogue (Micro-Dose): Triggers rapid, potent insulin release from the pancreas to control acute post-prandial (after-meal) glucose spikes. Pioglitazone (as Hydrochloride) USP/Ph.Eur. 15 mg The Sensitizer (Micro-Dose): Reverses deep cellular insulin resistance in skeletal muscle and adipose tissue. Metformin Hydrochloride USP/Ph.Eur. 500 mg (IR or ER) The Hepatic Anchor (Macro-Dose): Provides baseline suppression of liver glucose production. Frequently formulated in a sustained-release matrix to minimize severe GI side effects. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder (ER Polymer) / Lubricant (Engineered utilizing elite multi-stage geometric dilution to guarantee that the lethal 5mg micro-dose of Glibenclamide is flawlessly and evenly distributed throughout the massive 500mg Metformin matrix) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic diabetic dispensing regimens).
Linagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the highly hygroscopic combination.
Active Ingredient Strength Primary Clinical Function Linagliptin / Metformin HCl (IR) 2.5 mg / 500 mg
2.5 mg / 850 mg
2.5 mg / 1000 mgTwice-Daily Standard: Immediate-release units designed to be taken twice a day with meals to provide rapid, meal-time incretin spikes alongside baseline hepatic suppression. Linagliptin / Metformin HCl (ER) 5 mg / 1000 mg (ER) Once-Daily Premium Standard: High-efficacy Extended-Release therapy designed for ultimate patient compliance, delivering the full daily dose of Linagliptin while slowly trickling Metformin into the gut over 24 hours to prevent severe gastrointestinal side effects. Excipients Hypromellose (HPMC) / Copovidone / Microcrystalline Cellulose / Magnesium Stearate / Premium Moisture-Barrier Film ER Polymer / Binder / Diluent / Lubricant (Engineered utilizing elite Bilayer Rotary Presses to physically separate the delicate 2.5mg/5mg Linagliptin dose from the massive, moisture-drawing Metformin layer, preventing cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).
Metformin Hydrochloride & Glimepiride Tablets
FreeProduct Composition & Strength
We supply this product in Bilayer Tablets or Matrix Tablets packed in Alu-Alu or PVC/PVDC Blisters.
Product Strength Metformin HCl (SR) Glimepiride Common Name 500/1 mg 500 mg 1 mg G1 Tablet 500/2 mg 500 mg 2 mg G2 Tablet 1000/2 mg 1000 mg 2 mg Forte / DS Tablet 1000/4 mg 1000 mg 4 mg High Strength Metformin Tablet
FreeProduct Composition & Portfolio Range
We manufacture Metformin SR in the full spectrum of internationally recognized therapeutic strengths, utilizing a specialized slow-release scaffold to reduce dosing frequency to once daily.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride IP / BP / USP 500 mg Hydrophilic Dual-Polymer Sustained-Release Initial Titration: For low-dose introductory management and early-stage Type 2 stabilization. Metformin Hydrochloride IP / BP / USP 750 mg Hydrophilic Dual-Polymer Sustained-Release Intermediate Scaling: Step-up strength to optimize glycemic indices without increasing tablet count. Metformin Hydrochloride IP / BP / USP 1000 mg Hydrophilic Dual-Polymer Sustained-Release High-Potency Maintenance: Maximizes daily therapeutic saturation in an elegant, once-daily single tablet format. Metformin Tablets
FreeProduct Composition & Available Specifications
We supply Metformin Hydrochloride across the full spectrum of compendial strengths and advanced kinetic delivery platforms to optimize patient compliance and reduce gastrointestinal side effects.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Metformin Hydrochloride USP / BP / IP 500 mg Oral Solid Immediate-Release Film-Coated Tablet Introductory Titration: Baseline format designed for low-dose introductory management and gradual step-up scaling. Metformin Hydrochloride USP / BP / IP 850 mg Oral Solid Immediate-Release Film-Coated Tablet High-Density Single Dose: Intermediate strength optimized for achieving target daily therapeutic thresholds with fewer tablets. Metformin Hydrochloride USP / BP / IP 1000 mg Oral High-Mass Immediate-Release Tablet Maximal Saturation Therapy: High-strength configuration calibrated for advanced glycemic control and high-dose combinations. Metformin Hydrochloride USP / BP / IP 500 mg / 1000 mg SR Extended/Sustained-Release Hydrophilic Polymer Matrix Premium GI-Comfort Compliance: Once-daily formulation utilizing a dual-layer hydrogel matrix to release active drug slowly, completely eliminating gastrointestinal distress. Repaglinide & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined formulation.
Active Ingredient Strength Primary Clinical Function Repaglinide USP/Ph.Eur. 1 mg / 2 mg Short-acting meglitinide for rapid post-prandial (after-meal) insulin stimulation. Metformin Hydrochloride USP/Ph.Eur. 500 mg Global Clinical Standard: Biguanide for hepatic glucose suppression and insulin sensitization. Excipients Microcrystalline Cellulose / Povidone K30 / Croscarmellose Sodium / Poloxamer / Magnesium Stearate Diluent / Binder / Superdisintegrant / Surfactant (Engineered for immediate gastric dissolution and synchronized dual-absorption) *Pack Sizes: 10×10 or 3×10 Blisters (Optimized specifically for high-compliance 30-day chronic metabolic dispensing regimens tied directly to meal times).
Teneligliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Bilayer or Matrix Sustained-Release Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly hygroscopic Metformin component.
Active Ingredient Strength Primary Clinical Function Teneligliptin Hydrobromide Hydrate INN 20 mg Immediate-release DPP-4 inhibition for rapid post-prandial (after-meal) glucose control. Metformin Hydrochloride BP/Ph.Eur. 500 mg (Sustained-Release) Continuous 24-hour hepatic glucose suppression and peripheral insulin sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 24-hour kinetic release of Metformin) Vildagliptin & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Film-Coated Tablet (Available in Immediate or Bilayer Sustained-Release formats), packed strictly in high-barrier Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Vildagliptin is intensely sensitive to moisture degradation.
Active Ingredient Strength & Format Primary Clinical Use Vildagliptin INN/Ph.Eur. 50 mg (Immediate Release Layer) Rapid dissolution to block DPP-4 and manage post-prandial incretin levels. Metformin Hydrochloride USP/BP 500 mg / 850 mg / 1000 mg (IR or SR) Provides continuous baseline hepatic glucose suppression and peripheral sensitization. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Titanium Dioxide SR Polymer Matrix / Diluent / Film-Coating (Engineered for precise kinetic release) Voglibose & Metformin Tablets
FreeProduct Composition & Strength
We supply this product as a highly advanced Bilayer Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips. Alu-Alu packaging is completely non-negotiable, as Voglibose is highly sensitive to moisture degradation.
Active Ingredient Strength & Format Release Profile Function Voglibose USP/BP/JP 0.2 mg / 0.3 mg (Immediate Release Layer) Instantly dissolves in the gut to block carbohydrate absorption during the meal. Metformin Hydrochloride USP/BP 500 mg (Sustained Release Matrix) Slow-release polymer matrix providing continuous 24-hour hepatic suppression. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose SR Polymer Matrix / Diluent (Engineered to control precise dissolution rates)
